Table 1.
PKC | Tissue expressiona | Knockout mouse phenotype |
---|---|---|
PKCα | Ubiquitous, T cells, plasmacytoid dendritic cells (pDC) | T‐cell activation and T‐cell immunity defects148 |
PKCβ | Ubiquitous, B cells and mast cells | B‐cell signalling and survival defects; mast cells defects56, 149 |
PKCδ | Ubiquitous, B cells, mast cells, macrophages | B‐cell homeostasis defects150 |
PKCε | Ubiquitous | Macrophage activation defect16 |
PKCη | Ubiquitous, T cells and macrophages | T‐cell homeostasis and regulatory T cell function defects151, 152 |
PKCθ | T cells, mast cells, platelets, skeletal muscle | T‐cell activation defects37, 39 |
PKCζ | Ubiquitous | B‐cell receptor signalling defects; T helper type 2 response defects153 |
PKCλ/ι | Ubiquitous | Embryonic lethal154 |
PKCγ is preferably expressed in the brain.